Compare
IceCure Medical Ltd. vs Nuo Therapeutics, Inc. vs Tenon Medical, Inc. vs Intelligent Bio Solutions Inc.
| Latest fiscal year | IceCure Medical Ltd. ICCM | Nuo Therapeutics, Inc. AURX | Tenon Medical, Inc. TNON | Intelligent Bio Solutions Inc. INBS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-06-30 |
| Revenue | $3.38M | $3.31M | $3.94M | $4.22M |
| Revenue growth (YoY) | +2.7% | +142.7% | +20.4% | +38.1% |
| Gross margin | 36.3% | 66.9% | 59.8% | 48.6% |
| Operating margin | -446.7% | -76.0% | -324.3% | -299.1% |
| Net margin | -445.6% | -75.8% | -318.4% | -294.9% |
| Net income | -$15.06M | -$2.51M | -$12.56M | -$12.43M |
| EPS (Diluted) | $0.24 | n/a | -$1.70 | -$8.44 |
| Operating cash flow | -$14.57M | -$865.0K | -$10.74M | -$11.93M |
| Free cash flow | -$14.61M | -$1.14M | -$11.02M | -$12.05M |
| Cash & equivalents | $8.90M | $548.9K | $3.76M | $3.99M |
| Total assets | $13.89M | $1.85M | $10.76M | $11.94M |
| Total liabilities | n/a | $2.80M | $5.72M | $6.65M |
| Shareholders' equity | $9.05M | -$956.6K | $5.04M | $5.51M |
| Return on year-end equity | -166.4% | n/a | -249.1% | -225.6% |
| Shares outstanding | 73.12M | 48.18M | 10.85M | 2.91M |
Revenue, most recent five fiscal years
| Fiscal year | IceCure Medical Ltd. | Nuo Therapeutics, Inc. | Tenon Medical, Inc. | Intelligent Bio Solutions Inc. |
|---|---|---|---|---|
| Latest | $3.38M Ended 2025-12-31 | $3.31M Ended 2025-12-31 | $3.94M Ended 2025-12-31 | $4.22M Ended 2026-06-30 |
| 1 year earlier | $3.29M Ended 2024-12-31 | $1.37M Ended 2024-12-31 | $3.28M Ended 2024-12-31 | $3.05M Ended 2025-06-30 |
| 2 years earlier | $3.23M Ended 2023-12-31 | $608.5K Ended 2023-12-31 | $2.93M Ended 2023-12-31 | $3.11M Ended 2024-06-30 |
| 3 years earlier | $3.08M Ended 2022-12-31 | $112.2K Ended 2022-12-31 | $691.0K Ended 2022-12-31 | $1.26M Ended 2023-06-30 |
| 4 years earlier | $4.14M Ended 2021-12-31 | $0 Ended 2021-12-31 | $160.0K Ended 2021-12-31 | $437.1K Ended 2022-06-30 |